Investor mix
2 investors on record; lead investors include Ligand Pharmaceuticals.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |
Developer of therapies for treating inflammatory diseases
2 investors on record; lead investors include Ligand Pharmaceuticals.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |